for Fed head
? Unfortunately, the Bombay native has absolutely no time to spare
time right now, what with all his attention understandably focused
crisis currently consuming the subcontinent
. Still, as our top central banker, he could certainly be counted
on to deliver a much more palatable passage from India than
The Satanic Verses
that pass for FOMC meeting minutes these days. As a result of the
(^DJI) dropped for a sixth straight session, its triple-digit
decline taking the benchmark back below 15,000 for the first time
since the start of July. Winners among the wreckage included
), which has thus far enjoyed a stellar August even as other
) surged 33.48% to a 13-year peak on high hopes regarding its
potential treatment for pancreatic cancer, the disease that took
Steve Jobs from us far too soon. Elsewhere
), whose legendary leaders have filled obituary columns of late,
fell a respective 5.44% and 3.61% in action that was more
indicative of an overall torrid tape.
) tumbled 2.00% to lead blue chip laggards as the commodity complex
continued to crumble. However, putting lipstick on that particular
provide an inadvertent boon not just aluminum but
also cadmium and chromium
Today in economics, consensus calls for an increase in The
Conference Board's July leading indicators index at 10:00 a.m.
Eastern. In earnings action,
Abercrombie & Fitch
China Zenix Auto
(SHLD) are all due to report results.
(BCRX): Shares are begun with an Outperform at Wells Fargo.
Oppenheimer resumes Outperforms on
(VRTX), establishing respective price objectives of $300 and $105.
For the former, Eylea is impressing as a treatment for wet AMD
(Age-related Macular Degeneration), while VRTX has demonstrated
promise with its disease-modifying therapy Kalydeco for cystic
(XEC): Citigroup covers the energy outfit at a Neutral.
(INVN): Needham has a new Buy on the semiconductor name, assigning
a $20 target on a stock it says is well positioned in the
smartphone camera OIS (Optical Image Stabilizer) segment.
(MOV): The watchmaker, an
of late, is started with an Overweight at Stephens.
(SRE): SRE is started with a Buy at KeyBanc Capital.
Tesla Motors Inc
(TSLA): Elon Musk's cult electric car company, shares of which have
surged 407.94% in the past year, is assigned a lukewarm Hold at
Stifel amid understandable valuation issues. The brokerage believes
a tricky transition lies ahead, from being a "one-hit wonder" to
achieving "long-term sustainability." (This apparently unstoppable
stock is nonetheless edging up as I write, hence the question mark
in today's title.)
(ZNGA): The Benchmark Company has a Hold on the gaming firm whose
Words With Friends
. Although exponential expansion in smartphones and tablets offers
promise, other risks remain. Its target price is $2.98.
Stock Upgrades: If It's Thursday, Microsoft Corporation
Must be Back in Favor
Stock Downgrades: Target Corporation Is in the